Temperature

Phillip Eyler, Angel L. Mendez Named to Sleep Number Corporation Board of Directors

Online Retail, Consumer Electronics, Retail, Other Retail, Technology, Home Goods, Other Technology, Science, Sleep, Research, Lafayette College, Harman International, Ecosystem, MBA, Duke University, Sleep Number, Citigroup, Patient, Electronics, Bed, Leadership, Intelligence, Eyler, Board, CEO, Cisco Systems, Individual, GE, Gateway, Inc., Solution, Rollins College, Health, Executive, Ibach, Palm, Inc., BS, Temperature, Newsroom, Here Technologies, Purdue University, Board of directors, Management, Renewable energy
Monday, October 25, 2021 - 2:00pm

Sleep Number Corporation (Nasdaq: SNBR), the leader in sleep health, innovation, science, and research, today announced the appointment to its Board of Directors of Phillip Eyler, a transformational global leader of thermal technology solutions for automotive and medical customers, and Angel L. Mendez, an accomplished global operations executive in multinational technology companies.

Key Points: 
  • Sleep Number Corporation (Nasdaq: SNBR), the leader in sleep health, innovation, science, and research, today announced the appointment to its Board of Directors of Phillip Eyler, a transformational global leader of thermal technology solutions for automotive and medical customers, and Angel L. Mendez, an accomplished global operations executive in multinational technology companies.
  • Angel is a thought leader and trailblazer as an architect of end-to-end digital supply chains at global technology companies, continued Ibach.
  • Eyler and Mendez, whose appointments will be effective January 2, 2022, join a Board that is rich in diversity, including gender, Black, Latinx and LGBTQ+ members.
  • For life-changing sleep, visit SleepNumber.com or one of our more than 625 Sleep Number stores.

Elevate Capital Innovation Gap Fund: Oregon's First Commercialization Gap Fund to Support Science and Invention Based Startups

Woman, Veteran, Capital, Research, Oregon Business Development Department, Immunotherapy, Efficiency, LinkedIn, Vaccine, State, VAP, Elevate Capital, Twitter, Patient, View, Color, Technology, CPAP, Investment, Multimedia, Nervous system, Therapy, Temperature, LeapFrog Enterprises, Ventilator-associated pneumonia, Fund, AI, Mouth, Financial services, Cryptocurrency, Pharmaceutical industry
Monday, October 25, 2021 - 2:00pm

PORTLAND, Ore., Oct. 25, 2021 /PRNewswire/ -- Elevate Capital , Oregon's first inclusive venture capital fund that supports inclusion and diversity was proud to manage Business Oregon's first Commercialization Gap Fund , "the Gap Fund," a $2.5 million fund created to invest in early-stage, science-based Oregon-based startups.

Key Points: 
  • PORTLAND, Ore., Oct. 25, 2021 /PRNewswire/ -- Elevate Capital , Oregon's first inclusive venture capital fund that supports inclusion and diversity was proud to manage Business Oregon's first Commercialization Gap Fund , "the Gap Fund," a $2.5 million fund created to invest in early-stage, science-based Oregon-based startups.
  • Through Elevate Capital's work with the Gap Fund, the process has exposed a dire need for capital for Oregon's early-stage companies coming out of its research institutions.
  • Elevate Capital's support and management of the Commercialization Gap Fund have been integral to helping companies continue to raise additional funding.
  • Elevate Capital achieved all this despite the Gap Fund nearly disappearing due to the COVID-19-pandemic-induced economic downturn.

Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi

Safety, Failure, Pediatric Allergy and Immunology, CNS, Anaphylaxis, Nature, Marketing, Prodrug, Clobazam, COVID-19, Pediatrics, IND, Therapy, Incidence, Heart rate, PD, U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Food, Type 1, Regulation of tobacco by the U.S. Food and Drug Administration, Annual report, Diazepam, Company, Degenerative disease, Tmax, SL, Temperature, Intellectual property, Central nervous system, Compliance, Adrenaline, Industry, Drug development, New Drug Application, Children's Hospital Colorado, University of Colorado School of Medicine, SEC, Risk, PK, Growth, Immunology, Securities & Exchange Commission of Pakistan, Sale, Legislation, MD, Cmax, Technology, University, Patient, FDA, Epinephrine autoinjector, Patent, Emergency, Health, Parent, Biotransformation, Pharmaceutical industry, Security (finance)
Monday, October 25, 2021 - 1:31pm

Based on the study results, Aquestive plans on continuing development of the target formulation to take forward into a pivotal PK study.

Key Points: 
  • Based on the study results, Aquestive plans on continuing development of the target formulation to take forward into a pivotal PK study.
  • All treatment-emergent adverse events (TEAEs) deemed at least possibly related were mild to moderate in nature across cohorts.
  • The changes observed suggest a comparable effect for AQST-109 when compared to autoinjectors in healthy volunteers.
  • Aquestive Therapeutics is developing a sublingual (SL) film containing a prodrug of epinephrine as an alternative dosage form to epinephrine injection (1 mg/mL).

Amalgamated Bank Commits to Net Zero Targets by 2045

Zero, United Nations Global Compact, Method, Bank, Amalgamated Bank, Global Business Coalition, Goal, Global Alliance, WRI, Organization, Climate change, Adoption, NASDAQ, AMAL, Public policy, SEC, Climate, Social change, Investment, Phrase, Private, CEO, WWF, U.S. Securities and Exchange Commission, Nasdaq, Amalgamation, World Resources Institute, Global Alliance for Banking on Values, Temperature, Science, GLOBE, CDP, World Wide Fund for Nature, Renewable energy, Risk management
Monday, October 25, 2021 - 1:00pm

Amalgamated Bank is the first US bank to set full portfolio targets under the guidelines of the UN Net Zero Banking Alliance and is taking a rigorous approach to climate science aligned target setting.

Key Points: 
  • Amalgamated Bank is the first US bank to set full portfolio targets under the guidelines of the UN Net Zero Banking Alliance and is taking a rigorous approach to climate science aligned target setting.
  • Climate finance requires a global movement, which is why Amalgamated Bank has taken significant action by leading global economic initiatives and investments in sustainability, said Priscilla Sims Brown, President and CEO of Amalgamated Bank.
  • Ivan Frishberg, Chief Sustainability Officer added, Our Net Zero Climate Targets Report outlines our plan for how we expect to build and align with a climate safe future.
  • Amalgamated Bank is the countrys largest B Corp bank and a proud member of the Global Alliance for Banking on Values.

ProTek Devices Intros TVS Array for Circuit Protection in Common Computing Interfaces

Safety, Lightning, PCI Express, IEC, EFT, Name, TVS, UL, Electronics, SATA, ESD, NEMP, DVI, Investment, Insertion loss, HDMI, REACH, Radio, Temperature, Household, USB, Tin, EMI, EIA, Restriction of Hazardous Substances Directive, Electronic component, Printed circuit board
Monday, October 25, 2021 - 12:55pm

TEMPE, Ariz., Oct. 25, 2021 /PRNewswire-PRWeb/ -- ProTek Devices has introduced a steering diode / transient voltage suppressor array (TVS array) for circuit protection in common computing interfaces like HDMI and DVI, USB, SATA and PCIe, and more.

Key Points: 
  • TEMPE, Ariz., Oct. 25, 2021 /PRNewswire-PRWeb/ -- ProTek Devices has introduced a steering diode / transient voltage suppressor array (TVS array) for circuit protection in common computing interfaces like HDMI and DVI, USB, SATA and PCIe, and more.
  • Pricing information and purchasing details can be obtained by contacting any authorized worldwide distributor, representative, or directly with ProTek Devices.
  • ProTek Devices' circuit protection components include transient voltage suppressors, TVS diodes, steering diode TVS arrays, and other modules and components.
  • Its transient voltage suppressors (TVS array), steering diode TVS arrays, component modules, and more are widely used worldwide.

Johnson Controls Develops Industry-first AI Driven Digital Solution to Manage Clean Air, Energy, Sustainability, Comfort and Cost in Buildings

Massachusetts Institute of Technology, Infection, Decision-making, Goal, K-12, Industry, Name, Johnson Controls, Massachusetts, Twitter, Organization, HVAC, Algorithm, Health, POV, Transport, History, Carbon footprint, Weather, ESG, Chemical engineering, NYSE, Risk, Airport, Time, Tenant, Software, Climate change, JCI, Movement, Work, Public health, Artificial intelligence, Solution, Mathematics, Temperature, School, Disinfectant, AI, Heating, ventilation, and air conditioning, Publishing
Monday, October 25, 2021 - 12:35pm

Johnson Controls OpenBlue Enterprise Manager solution helps facilities managers optimize building portfolio performance through advanced data analytics and artificial intelligence.

Key Points: 
  • Johnson Controls OpenBlue Enterprise Manager solution helps facilities managers optimize building portfolio performance through advanced data analytics and artificial intelligence.
  • The solution is a comprehensive suite of applications from Johnson Controls used to monitor and improve indoor air quality, energy efficiency, tenant satisfaction, asset performance, maintenance operations, space performance and the comfort of all occupants.
  • Analytics and AI solutions have historically focused on solving for one goal at a time clean air, energy/carbon, wellness, asset health, comfort, experience, space utilization, etc.
  • "Supporting healthy and sustainable buildings is at the core of Johnson Controls priorities and the solutions and services we bring to market.

CLS Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors

Safety, Hospital, Workflow, Medicine, Patient, FLA, Biopsy, CLS, Company, Anticonvulsant, CEO, CT, Nasdaq, Temperature, Prostate cancer, GLOBE, Medical imaging
Monday, October 25, 2021 - 12:00pm

LUND, Sweden, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a new generation of its TRANBERG Thermal Therapy System is being evaluated for MRI-US, fusion-guided laser ablation for the minimally-invasive, targeted focal therapy of prostate tumors.

Key Points: 
  • LUND, Sweden, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a new generation of its TRANBERG Thermal Therapy System is being evaluated for MRI-US, fusion-guided laser ablation for the minimally-invasive, targeted focal therapy of prostate tumors.
  • CLSs goal is to enable high precision, focal laser ablation of prostate cancer tumors to be performed under local anesthetic in an office setting or clinic as well as hospitals.
  • CLSs TRANBERG Thermal Therapy System has successfully performed MRI-guided, focal laser ablation treatments for hundreds of patients suffering from early stage prostate cancer, stated Dan Mogren, acting CEO for CLS.
  • High precision, image-guided focal laser ablation performed using the TRANBERG Thermal Therapy System is safe and offers a focal therapy option for treatment of prostate tumors while minimizing side effects and maintaining the patients quality of life.

CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors

Safety, Hospital, Workflow, Medicine, Patient, FLA, Biopsy, CLS, Company, CEO, CT, Nasdaq, Temperature, Prostate cancer, GLOBE, Medical imaging
Monday, October 25, 2021 - 12:00pm

IRVINE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a new generation of its TRANBERG Thermal Therapy System is being evaluated for MRI-US, fusion-guided laser ablation for the minimally-invasive, targeted focal therapy of prostate tumors.

Key Points: 
  • IRVINE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a new generation of its TRANBERG Thermal Therapy System is being evaluated for MRI-US, fusion-guided laser ablation for the minimally-invasive, targeted focal therapy of prostate tumors.
  • CLSs goal is to enable high precision, focal laser ablation of prostate cancer tumors to be performed under local anesthetic in an office setting or clinic as well as hospitals.
  • CLSs TRANBERG Thermal Therapy System has successfully performed MRI-guided, focal laser ablation treatments for hundreds of patients suffering from early stage prostate cancer, stated Dan Mogren, acting CEO for CLS.
  • High precision, image-guided focal laser ablation performed using the TRANBERG Thermal Therapy System is safe and offers a focal therapy option for treatment of prostate tumors while minimizing side effects and maintaining the patients quality of life.

Taoglas Demonstrates Warehouse Staging Area Capacity Solution at Mobile World Congress LA Using Latest Machine Vision Technologies

Networks, Hardware, Audio, Video, Technology, Software, Safety, RF, Efficiency, Technology, Entrepreneurship, Shock, EDGE, CO2, Motor vehicle, Transport, Vibration, Original equipment manufacturer, Altitude, Waste management, Time, Software, Nvidia Jetson, OpenVINO, OpenCV, IOT, Mobile World Congress, Artificial intelligence, Solution, Temperature, Wi-Fi, Mobile, Automation, AI, Retail, Medical device
Monday, October 25, 2021 - 12:01pm

MOBILE WORLD CONGRESS -- Taoglas, a leading enabler of digital transformation through IoT, today announces its new Taoglas EDGE Vision technology that will revolutionise processes for numerous vertical IoT applications.

Key Points: 
  • MOBILE WORLD CONGRESS -- Taoglas, a leading enabler of digital transformation through IoT, today announces its new Taoglas EDGE Vision technology that will revolutionise processes for numerous vertical IoT applications.
  • To illustrate the capabilities of Taoglas highly experienced machine vision AI engineering team, Taoglas is demonstrating an interactive version of this technology at the Mobile World Congress event in LA with a warehouse staging area capacity solution.
  • The warehouse staging area capacity solution can be created to alert via Wi-Fi, Bluetooth or cellular when available capacity exceeds criteria.
  • From the initial strategy definition through to the design, build, deployment and management of your solution, Taoglas oers the complete solution stack for your machine vision AI project.

Resilia Pharmaceuticals Acquires License to Commercialize Solace™ Eczema Cream in the United States

Cream, COVID-19, Detergent, Atopic dermatitis, Quality of life, PEA, Disease, Organic acid, Dermatology, Amazon, Cholesterol, Ceramide, Journal of the European Academy of Dermatology and Venereology, Patient, Econazole, Itchy, Dermatitis, LLC, OTC, Growth, Board, Skin, Bacteria, Acquisition, Temperature, Allergen, Director, Treatment, Hormone, Pharmaceutical industry, Cosmetics
Monday, October 25, 2021 - 11:30am

ATLANTA, Oct. 25, 2021 /PRNewswire/ --Resilia Pharmaceuticals, Inc. announced the signing today of a license agreement with Pelle Ventures, LLC granting Resilia the rights to make, market and sell Solace Eczema Cream, a medical device, as an OTC product in the United States.

Key Points: 
  • ATLANTA, Oct. 25, 2021 /PRNewswire/ --Resilia Pharmaceuticals, Inc. announced the signing today of a license agreement with Pelle Ventures, LLC granting Resilia the rights to make, market and sell Solace Eczema Cream, a medical device, as an OTC product in the United States.
  • "We are delighted to add Solace Cream to the Resilia portfolio of dermatology products, said Harsha Murthy, Executive Chairman of the Board of Directors at Resilia Pharmaceuticals.
  • Resilia is proud to be able to offer patients an effective and safe product like Solace Cream, a product previously available only by prescription.
  • Resilia Pharmaceuticals will begin work immediately to make Solace Cream available on Amazon and plans to expand Amazon promotion.